Study Suggests Lung Cancer Screening Criteria May Not Capture All Smokers Who Need It
March 31st 2015Eligibility criteria set by the Centers for Medicare & Medicaid Services for coverage of low-dose computed tomography for individuals deemed at high risk for lung cancer may actually exclude many potential lung cancer patients who would benefit from screening.
Ovarian Cancer Subtypes May Predict Response to Bevacizumab
June 9th 2014Sean Dowdy, MD, a Mayo Clinic gynecologic oncologist discusses a study showing molecular sequencing could identify ovarian cancer patients who are most likely to benefit from treatment with bevacizumab (Avastin), a Mayo Clinic-led study has found.
Minimizing Axillary Surgery for Patients With Node-Positive Breast Cancer
March 6th 2014As advances in systemic therapy improve our ability to individualize breast cancer treatment, and improve response rates and outcomes, it is important to reevaluate the most appropriate form of local-regional management.
Some With Micropapillary Urothelial Carcinoma May Benefit From HER2-Targeted Treatment
February 27th 2014Some patients with micropapillary urothelial carcinoma face a three-fold risk of cancer death because their disease amplifies HER2 and overexpresses its protein product, and there may be a role for treatment of the condition with HER2- targeted agent trastuzumab, which has vastly increased the odds of survival for eligible patients with breast cancer.
Ginseng Improves Cancer-Related Fatigue in Phase III Trial
September 3rd 2013A multisite, randomized, double-blind trial evaluating the fatigue-ameliorating properties of American ginseng in cancer patients and recent survivors has found the herb to be helpful in reducing some aspects of CRF, with the benefit strongest among patients currently in treatment.
Cryoablation May Offer Option for Metastatic Lung Tumors
The results of the first prospective multicenter trial of cryoablation in lung cancer show that this emerging treatment may be a safe, effective, and minimally invasive method of helping a specific group of patients with advanced disease.